These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35165917)

  • 1. Optimal adaptive promising zone designs.
    Mehta C; Bhingare A; Liu L; Senchaudhuri P
    Stat Med; 2022 May; 41(11):1950-1970. PubMed ID: 35165917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal flexible sample size design with robust power.
    Zhang L; Cui L; Yang B
    Stat Med; 2016 Aug; 35(19):3385-96. PubMed ID: 26999385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal promising zone designs.
    Hsiao ST; Liu L; Mehta CR
    Biom J; 2019 Sep; 61(5):1175-1186. PubMed ID: 30411405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation.
    Levin GP; Emerson SC; Emerson SS
    Stat Med; 2013 Apr; 32(8):1259-75; discussion 1280-2. PubMed ID: 23081665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive trial designs.
    Lai TL; Lavori PW; Shih MC
    Annu Rev Pharmacol Toxicol; 2012; 52():101-10. PubMed ID: 21838549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size re-estimation in Phase 2 dose-finding: Conditional power versus Bayesian predictive power.
    Liu Q; Hu G; Ye B; Wang S; Wu Y
    Pharm Stat; 2023 Mar; 22(2):349-364. PubMed ID: 36418025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
    Ryan EG; Brock K; Gates S; Slade D
    BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive sample size modification in clinical trials: start small then ask for more?
    Jennison C; Turnbull BW
    Stat Med; 2015 Dec; 34(29):3793-810. PubMed ID: 26172385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.
    Wang Y; Travis J; Gajewski B
    BMC Med Res Methodol; 2022 Apr; 22(1):118. PubMed ID: 35448963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal adaptive group sequential design with flexible timing of sample size determination.
    Cui L; Zhang L; Yang B
    Contemp Clin Trials; 2017 Dec; 63():8-12. PubMed ID: 28455234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising zone two-stage design for a single-arm study with binary outcome.
    Shan G
    Stat Methods Med Res; 2023 Jun; 32(6):1159-1168. PubMed ID: 36998163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials - an example in hemato-oncology.
    Jacob L; Uvarova M; Boulet S; Begaj I; Chevret S
    BMC Med Res Methodol; 2016 Jun; 16():67. PubMed ID: 27250349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian basket trial design with false-discovery rate control.
    Zabor EC; Kane MJ; Roychoudhury S; Nie L; Hobbs BP
    Clin Trials; 2022 Jun; 19(3):297-306. PubMed ID: 35128970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.
    Herrmann C; Pilz M; Kieser M; Rauch G
    Stat Med; 2020 Jul; 39(15):2067-2100. PubMed ID: 32249968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size re-estimation in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Stat Methods Med Res; 2019 Jun; 28(6):1852-1878. PubMed ID: 29869564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stepwise two-stage sample size adaptation.
    Wan H; Ellenberg SS; Anderson KM
    Stat Med; 2015 Jan; 34(1):27-38. PubMed ID: 25252082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving clinical trials using Bayesian adaptive designs: a breast cancer example.
    Hong W; McLachlan SA; Moore M; Mahar RK
    BMC Med Res Methodol; 2022 May; 22(1):133. PubMed ID: 35508968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional estimation in two-stage adaptive designs.
    Broberg P; Miller F
    Biometrics; 2017 Sep; 73(3):895-904. PubMed ID: 28099993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian sequential design with binary outcome.
    Zhu H; Yu Q; Mercante DE
    Pharm Stat; 2017 May; 16(3):192-200. PubMed ID: 28251815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.